A Double-Blind Crossover Comparison of Orudis® (Ketoprofen) and Indomethacin in the Treatment of Rheumatoid Arthritis
- 1 November 1976
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 4 (6) , 427-431
- https://doi.org/10.1177/030006057600400608
Abstract
Twenty-three patients with rheumatoid arthritis participated in a double-blind crossover investigation of ketoprofen (Orudis) and indomethacin. Ratings which assessed the degree of joint involvement showed consistently greater improvement with Orudis, and side-effects occurred with less frequency. The majority of patients expressed a definite preference for Orudis.This publication has 4 references indexed in Scilit:
- Double-blind Cross-over Study of Ketoprofen and Ibuprofen in Management of Rheumatoid ArthritisBMJ, 1973
- DOUBLE-BLIND CROSS-OVER STUDY OF ORUDIS AND PLACEBO IN FIFTY PATIENTS WITH RHEUMATOID ARTHRITISRheumatology, 1973
- Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.Annals of the Rheumatic Diseases, 1973
- Orudis in Management of Rheumatoid Arthritis and Osteoarthrosis of the Hip: Comparison with IndomethacinBMJ, 1972